Terms: = Colorectal cancer AND WWTR1, ENSG00000018408, 25937, Q9GZV5, DKFZP586I1419
5 results:
1. The Hippo pathway terminal effector TAZ/wwtr1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells.
Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A
BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073
[TBL] [Abstract] [Full Text] [Related]
2. YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy.
Thompson BJ
Bioessays; 2020 May; 42(5):e1900162. PubMed ID: 32128850
[TBL] [Abstract] [Full Text] [Related]
3. Epithelioid Hemangioendothelioma of the Bowel in Crohn's Disease: The First Reported Case.
Spasic S; Brcic I; Freire R; Garcia-Buitrago MT; Rosenberg AE
Int J Surg Pathol; 2019 Jun; 27(4):423-426. PubMed ID: 30238810
[TBL] [Abstract] [Full Text] [Related]
4. TAZ expression as a prognostic indicator in colorectal cancer.
Yuen HF; McCrudden CM; Huang YH; Tham JM; Zhang X; Zeng Q; Zhang SD; Hong W
PLoS One; 2013; 8(1):e54211. PubMed ID: 23372686
[TBL] [Abstract] [Full Text] [Related]
5. Lentivirus-mediated RNA interference targeting wwtr1 in human colorectal cancer cells inhibits cell proliferation in vitro and tumor growth in vivo.
Pan J; Li S; Chi P; Xu Z; Lu X; Huang Y
Oncol Rep; 2012 Jul; 28(1):179-85. PubMed ID: 22470139
[TBL] [Abstract] [Full Text] [Related]